Legal & General Group
TMO icon

Legal & General Group’s Thermo Fisher Scientific TMO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$948M Buy
2,338,556
+59,738
+3% +$24.2M 0.24% 73
2025
Q1
$1.13B Buy
2,278,818
+16,278
+0.7% +$8.1M 0.31% 51
2024
Q4
$1.18B Sell
2,262,540
-110,111
-5% -$57.3M 0.31% 44
2024
Q3
$1.47B Buy
2,372,651
+18,579
+0.8% +$11.5M 0.39% 36
2024
Q2
$1.3B Sell
2,354,072
-130,029
-5% -$71.9M 0.37% 37
2024
Q1
$1.44B Sell
2,484,101
-53,485
-2% -$31.1M 0.42% 35
2023
Q4
$1.35B Buy
2,537,586
+20,203
+0.8% +$10.7M 0.42% 36
2023
Q3
$1.27B Sell
2,517,383
-92,725
-4% -$46.9M 0.44% 33
2023
Q2
$1.36B Buy
2,610,108
+50,802
+2% +$26.5M 0.44% 36
2023
Q1
$1.48B Buy
2,559,306
+32,431
+1% +$18.7M 0.53% 28
2022
Q4
$1.39B Sell
2,526,875
-72,003
-3% -$39.7M 0.53% 28
2022
Q3
$1.32B Sell
2,598,878
-127,345
-5% -$64.6M 0.52% 29
2022
Q2
$1.48B Sell
2,726,223
-25,749
-0.9% -$14M 0.52% 29
2022
Q1
$1.63B Buy
2,751,972
+174,785
+7% +$103M 0.49% 30
2021
Q4
$1.72B Sell
2,577,187
-123,129
-5% -$82.2M 0.52% 25
2021
Q3
$1.54B Buy
2,700,316
+129,279
+5% +$73.9M 0.5% 29
2021
Q2
$1.3B Buy
2,571,037
+144,560
+6% +$72.9M 0.43% 38
2021
Q1
$1.11B Sell
2,426,477
-37,838
-2% -$17.3M 0.41% 42
2020
Q4
$1.15B Buy
2,464,315
+43,584
+2% +$20.3M 0.45% 41
2020
Q3
$1.07B Sell
2,420,731
-105,133
-4% -$46.4M 0.48% 37
2020
Q2
$915M Sell
2,525,864
-51,210
-2% -$18.6M 0.44% 44
2020
Q1
$731M Buy
2,577,074
+81,301
+3% +$23.1M 0.43% 45
2019
Q4
$811M Buy
2,495,773
+58,312
+2% +$18.9M 0.39% 47
2019
Q3
$710M Sell
2,437,461
-4,408
-0.2% -$1.28M 0.37% 48
2019
Q2
$717M Sell
2,441,869
-12,395
-0.5% -$3.64M 0.39% 47
2019
Q1
$672M Buy
2,454,264
+476,994
+24% +$131M 0.38% 53
2018
Q4
$442M Buy
1,977,270
+130,064
+7% +$29.1M 0.34% 58
2018
Q3
$451M Buy
1,847,206
+70,872
+4% +$17.3M 0.32% 62
2018
Q2
$368M Sell
1,776,334
-77,317
-4% -$16M 0.28% 73
2018
Q1
$383M Sell
1,853,651
-117,232
-6% -$24.2M 0.29% 70
2017
Q4
$374M Buy
1,970,883
+2,433
+0.1% +$462K 0.27% 79
2017
Q3
$372M Buy
1,968,450
+41,041
+2% +$7.76M 0.28% 75
2017
Q2
$336M Buy
1,927,409
+63,359
+3% +$11.1M 0.27% 81
2017
Q1
$286M Buy
1,864,050
+69,279
+4% +$10.6M 0.24% 91
2016
Q4
$253M Buy
1,794,771
+25,400
+1% +$3.58M 0.24% 96
2016
Q3
$281M Sell
1,769,371
-37,585
-2% -$5.98M 0.29% 77
2016
Q2
$267M Buy
1,806,956
+101,399
+6% +$15M 0.28% 77
2016
Q1
$241M Buy
1,705,557
+16,966
+1% +$2.4M 0.27% 86
2015
Q4
$240M Buy
1,688,591
+36,270
+2% +$5.15M 0.27% 83
2015
Q3
$202M Buy
1,652,321
+50,142
+3% +$6.13M 0.25% 90
2015
Q2
$208M Buy
1,602,179
+22,497
+1% +$2.92M 0.24% 96
2015
Q1
$212M Sell
1,579,682
-18,114
-1% -$2.43M 0.25% 90
2014
Q4
$200M Sell
1,597,796
-71,844
-4% -$9M 0.24% 100
2014
Q3
$203M Sell
1,669,640
-41,986
-2% -$5.11M 0.24% 98
2014
Q2
$202M Buy
1,711,626
+69,926
+4% +$8.25M 0.24% 101
2014
Q1
$197M Buy
1,641,700
+35,932
+2% +$4.32M 0.24% 99
2013
Q4
$179M Buy
1,605,768
+4,652
+0.3% +$518K 0.22% 114
2013
Q3
$148M Sell
1,601,116
-21,218
-1% -$1.96M 0.19% 122
2013
Q2
$137M Buy
+1,622,334
New +$137M 0.19% 122